| 标题 |
Multicentre phase II trial of plasminogen activator inhibitor-1 inhibitor (TM5614) plus nivolumab in Japanese advanced melanoma patients: immune resistance remains one of the major efforts in melanoma research |
| 网址 | |
| DOI | |
| 其它 |
期刊:British Journal of Dermatology 作者:Johannes Kleemann; Bastian Schilling 出版日期:2024-07-02 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)